title: Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.
authors.forename: R T
authors.initials: RT
authors.lastname: Tsuyuki
authors.forename: B
authors.initials: B
authors.lastname: Walters
authors.forename: R
authors.initials: R
authors.lastname: Yim
authors.forename: K K
authors.initials: KK
authors.lastname: Teo
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D004359:Drug Therapy, Combination; D006331:Heart Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010818:Practice Patterns, Physicians'; D012189:Retrospective Studies; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin